Financhill
Back

Novo Nordisk A/S Quote, Financials, Valuation and Earnings

Novo Nordisk A/S Price Quote

$123.06
+0.01 (+-0.77%)
(Updated: May 4, 2024 at 6:30 AM ET)

Novo Nordisk A/S Key Stats

Buy
58
Novo Nordisk A/S (NVO) is a Buy

Day range:
$121.29 - $123.77
52-week range:
$75.56 - $138.28
Dividend yield:
1.12%
P/E ratio:
45.52
P/S ratio:
15.53
P/B ratio:
38.37%

Volume:
5.7M
Avg. volume:
3.9M
1-year change:
46.69%
Market cap:
$548.9B
Revenue:
$33.7B
EPS:
$2.9

How Much Does Novo Nordisk A/S Make?

Is Novo Nordisk A/S Growing As A Company?

  • What Is Novo Nordisk A/S's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.24%
  • What Is Novo Nordisk A/S's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.31%

Novo Nordisk A/S Stock Price Performance

  • Did Novo Nordisk A/S Stock Go Up Last Month?
    Novo Nordisk A/S share price went down by -3.1% last month
  • Did NVO's Share Price Rise Over The Last Year?
    NVO share price rose by 46.69% over the past 1 year

What Is Novo Nordisk A/S 52-Week High & Low?

Novo Nordisk A/S Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk A/S?

  • How Much Debt Does Novo Nordisk A/S Have?
    Total long term debt quarterly is $3.9B
  • How Much Cash Does Novo Nordisk A/S Have?
    Cash and short term investments quarterly total is $1.3B
  • What Is Novo Nordisk A/S’s Book Value Per Share?
    Book value per share is 3.21

Is Novo Nordisk A/S Cash Flow Positive?

  • What Is NVO Cash Flow From Operations?
    Cash flow from operations (TTM) is $13.6B
  • What Is Novo Nordisk A/S’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$10B
  • What Is Novo Nordisk A/S’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.8B

Novo Nordisk A/S Return On Invested Capital

  • Is Management Doing A Good Job?
    NVO return on invested capital is 75.11%
  • What Is Novo Nordisk A/S Return On Assets?
    ROA measures how assets are converting to revenues and is 30.93%
  • What Is NVO Return On Equity?
    ROE is a measure of profitability and is 95.26%

Novo Nordisk A/S Earnings Date & Stock Price

Novo Nordisk A/S Competitors

Novo Nordisk A/S Dividend Yield

Novo Nordisk A/S Analyst Estimates

YoY Growth Past Surprise
EPS: 30.68% 5.64%
Revenue: 23.68% 2.97%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 138.80
Upside from Last Price: 12.8%

Major Shareholders

  • How many NVO shares are owned by institutional investors?
    399.1M NVO shares are owned by institutional investors
  • How many NVO shares are owned by insiders?
    0 NVO shares are owned by insiders